Table 6.
Injection Group | Control Group | P | |
---|---|---|---|
Anterior uveitis | 7 (33.3 %) | 10 (47.6 %) | 0.42 |
Worsened corneal edema | 2 (9.5 %) | 2 (9.1 %) | 0.96 |
Hyphema | 9 (42.9 %) | 9 (40.9 %) | 0.90 |
Vitreous hemorrhage | 2 (9.5 %) | 5 (22.7 %) | 0.23 |
Transient ocular hypertension | 2 (9.5 %) | 4 (18.2 %) | 0.41 |
Malignant glaucoma | 0 | 0 | |
Sustained low IOP | 0 | 0 | |
Drainage tube obstruction/displacement/exposure | 3 (14.3 %) | 4 (18.2 %) | 0.73 |
Lens opacity | 1 (4.8 %) | 0 | |
Choroidal hemorrhage/detachment | 0 | 1 (4.5 %) | |
Retinal detachment | 0 | 0 | |
Conjunctival retraction/rupture | 0 | 1 (4.5 %) | |
Endophthalmitis | 0 | 0 | |
Loss of light perception | 0 | 0 | |
Total | 12 (57.1 %) | 14 (63.6 %) | 0.66 |
Note: The differences in postoperative complications were compared between the two groups using the chi-square or corrected chi-square test